Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Exploring Private Clinics And Online Services If youre stuck facing long NHS waiting times or just want a quicker, more direct way to get treatment, the private sector is well worth considering
Meet your new best friend: fiber
Beyond weight loss, Tirzepatide helps improve various markers of metabolic health
Retatrutide (development code LY3437943) is an investigational injectable medicine developed by Eli Lilly and Company, currently under clinical evaluation for the treatment of obesity and type 2 diabetes
US$ 22.93
US$ 20.86
US$ 25.81
US$ 29.21
US$ 22.68
US$ 28.70
